Clinical Trial Detail

NCT ID NCT02195011
Title Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors SCRI Development Innovations, LLC
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.